This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Kanagawa Prefectural Hospital Organization, The University of Tokyo. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2024
Title: Shoutaro Tsuji: Innovator in Mesothelioma Detection and Treatment
Introduction
Shoutaro Tsuji is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical diagnostics and treatment, particularly concerning mesothelioma. His innovative work has led to the development of a unique antibody that plays a crucial role in the detection and treatment of this challenging disease.
Latest Patents
Tsuji holds a patent for an "Antibody binding to HEG1 and use of the antibody for detection and treatment of mesothelioma." This invention provides an antibody specifically designed for detecting mesothelioma, showcasing high specificity and sensitivity. The patent also outlines a method for diagnosing mesothelioma using this antibody, along with a reagent and a kit for diagnostic purposes. Furthermore, it includes a pharmaceutical composition containing the antibody or its antigen-binding fragment for treating mesothelioma.
Career Highlights
Throughout his career, Shoutaro Tsuji has worked with esteemed institutions such as the Kanagawa Prefectural Hospital Organization and The University of Tokyo. His experience in these organizations has allowed him to advance his research and contribute to significant medical innovations.
Collaborations
Tsuji has collaborated with notable colleagues, including Taihei Kageyama and Kota Washimi. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.
Conclusion
Shoutaro Tsuji's work in developing an antibody for mesothelioma detection and treatment exemplifies the impact of innovation in healthcare. His contributions are vital in the ongoing fight against this serious disease, and his patent reflects a significant advancement in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile